| related words |
| carcinogenicity |
| abthrax |
| decodeme |
| sanctura |
| arcalyst |
| analyzer |
| advexin |
| synthesis |
| finishing |
| bioequivalence |
| neuropathic |
| ipilimumab |
| preapproval |
| biosensors |
| outlicensing |
| enzyme |
| norcross |
| ppi |
| expression |
| apio |
|
| related documents |
| 831547--3/14/2008--SPECTRUM_PHARMACEUTICALS_INC |
|
| related topics |
| {product, candidate, development} |
| {loss, insurance, financial} |
| {provision, law, control} |
| {stock, price, operating} |
| {debt, indebtedness, cash} |
| {tax, income, asset} |
| {financial, litigation, operation} |
| {stock, price, share} |
| {investment, property, distribution} |
| {operation, natural, condition} |
| {personnel, key, retain} |
| {condition, economic, financial} |
| {operation, international, foreign} |
| {system, service, information} |
| {gas, price, oil} |
| {regulation, change, law} |
| {customer, product, revenue} |
| {cost, contract, operation} |
| {regulation, government, change} |
| {acquisition, growth, future} |
|